Back to Search
Start Over
Adjuvant ipilimumab and nivolumab in renal cell carcinoma: more questions than answers.
- Source :
-
Lancet . Mar2023, Vol. 401 Issue 10379, p796-798. 3p. - Publication Year :
- 2023
- Subjects :
- *RENAL cell carcinoma
*NIVOLUMAB
*IPILIMUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 01406736
- Volume :
- 401
- Issue :
- 10379
- Database :
- Academic Search Index
- Journal :
- Lancet
- Publication Type :
- Academic Journal
- Accession number :
- 162326871
- Full Text :
- https://doi.org/10.1016/S0140-6736(22)02631-9